Clinical Trial Update: Oxaliplatin, Fluorouracil, Erlotinib Hydrochloride, and Radiation Therapy Before Surgery and Erlotinib Hydrochloride After Surgery in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluates a multimodal approach using oxaliplatin, fluorouracil, and erlotinib with pre-surgical radiation, followed by adjuvant erlotinib, i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Esophagus
• Adenocarcinoma of the Gastroesophageal Junction
• Adenocarcinoma of the Stomach
• Esophageal Cancer
• Gastric Cancer
• Squamous Cell Carcinoma of the Esophagus

Drugs mentioned

• Adrucil (5-fluorouracil)
• Eloxatin (oxaliplatin)
• Tarceva (erlotinib)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction | Phase 1 | Status: COMPLETED